Trends of antihypertensive use among patients with cancer and hypertension in the United States 2002-2019.

ABSTRACT:

Background

Hypertension (HTN) is the most frequently reported comorbidity in patients with malignancy. This study was conducted to assess the trend of different antihypertensive (AHT) medications used in cancer patients.

Methods

We used the Medical Expenditure Panel Survey (MEPS) database from 2002 to 2019 to identify adult (age >18 years) cancer patients with HTN using appropriate International Classification of Disease (ICD)-9 and ICD-10 codes. Benign and uncertain neoplasms were excluded. P-trend values were calculated using weighted logistic regression with "year" as the predictor variable.

Results

We identified ∼46 million adult hypertensive cancer patients with an increasing trend from 2002 to 2019 (3.3 m-6.7 m). Angiotensin-converting enzyme inhibitors/a

SUBMITTER: Thyagaturu H 

PROVIDER: S-EPMC10368817 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature